Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?
ArchivedNational Institutes of Health
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate the use of existing biospecimens and datasets (i.e., secondary analysis) which will increase our understanding of the clinical significance of clonal hematopoiesis (CH) mutations, their causality, directionality, relationships with different human aging phenotypes, and the underlying biological mechanisms.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH Grants Information<br/>grantsinfo@nih.gov
grantsinfo@nih.gov
- PostedMay 17, 2023
- ClosesOct 23, 2023
- Award ceiling$1,000,000
- CFDA93.866
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro